Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Educational Development Q3 Sales $30.27M Miss $46.00M Estimate

Educational Development (NASDAQ:EDUC) reported quarterly sales of $30.27 million which missed the analyst consensus estimate of $46.00 million by 34.20 percent. This is a 32.90 percent decrease over sales of $45.11
byMichael Horton
January 5, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Educational Development (NASDAQ:EDUC) reported quarterly sales of $30.27 million which missed the analyst consensus estimate of $46.00 million by 34.20 percent. This is a 32.90 percent decrease over sales of $45.11 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Ardelyx Announces Acceptance Of New Drug Application For Tenapanor For Hyperphosphatemia In China; Triggers $2M Milestone Payment To Ardelyx Under The Terms Of The License Agreement Between Co And Shanghai Fosun Pharmaceutical Industrial Development C…

By Happy Mohamed
July 13, 8:06 AM
Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that

ARDX